FDRs also express increased levels of rheumatic regional pain syndromes and RA-related autoantibodies such as ACPA and rheumatoid factor (RF) in comparison to the general population, which may be indicative of even further progression to clinical RA [60]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.